Skip to content
Projects
Close Projects
Open Projects
Technology Platform
Pipeline
Stem Cell Therapy
Targeted cancer therapy
Indications
Publications
Investors
Close Investors
Open Investors
Share Information
Financial Reports
Financial Calendar
Analyses
Share issues
Management & Board
Corporate Governance
General Meetings
IR Contact / Certified Adviser
Media
Close Media
Open Media
Press Releases
Xintelling – Newsletter
Videos
Xintela in the news
Events
About Xintela
Contact
SV
SV
SV
News and Media
Here you can read more about Xintela’s news.
Press Releases
Alla
News
Regulatory
MAR
Search
April 30, 2026
Xintela AB publishes Annual Report 2025
April 14, 2026
Xintela granted US patent for XSTEM treatment of difficult-to-heal wounds and skin defects
April 13, 2026
Xintela publication on EQSTEM treatment of horses in a preclinical osteoarthritis study awarded best basic science paper
February 27, 2026
Xintela AB Year-end Report 2025
February 20, 2026
Xintelling No. 1 2026
February 13, 2026
Xintela completes clinical study with XSTEM in difficult-to-heal leg ulcers
Showing Slide 1 of 7
Load more
– Newsletter
February 20, 2026
Xintelling No. 1 2026
October 30, 2025
Xintelling No. 2 2025
May 12, 2025
Xintelling No. 6 2025
December 27, 2024
Xintelling No. 5 2024
October 7, 2024
Xintelling, No. 4 2024
July 1, 2024
Xintelling, No. 3 2024
Showing Slide 1 of 7
Load more
Video
Professor Stephen Hall comments on Xintela’s study results
Xintela | Investing in Life Science 2025
Xintela in the news
4 March, 2026
Biostock article
Xintela's CEO sums up 2025 and looks ahead
27 November, 2025
Biostock article
Xintela aims for partnership – issue strengthens position
26 November, 2025
Biostock article
Full focus on commercial agreements – Xintela's CEO comments
6 November, 2025
Biostock article
Xintela reports clinical progress and strengthens collaborations
21 August, 2025
Biostock article
Peter Ekolind returns to Xintela
2 June, 2025
Biostock article
Xintela's CEO comments on the latest progress
Showing Slide 1 of 7
Load more
Event
Projects
Technology Platform
Pipeline
Stem cell therapy
Targeted cancer therapy
Indications
Publications
Investors
Share Information
Financial Reports
Financial Calendar
Analyses
Share issues
Management & Board
Corporate Governance
General Meetings
IR-contact / Certified Adviser
Media
Press Releases
Xintelling – Newsletter
Videos
Xintela in the news
Events
About Xintela
Contact
Research & Development
Integrin α10β1
Pipeline
TARG9
TARG10
Cancer Indications
About Targinta
Management & Board
Business Development
Invest
Contact